Riskpilot← Back to searchSign inGet full accessDocrates Oy
OYDissolvedY-tunnus 2050681-8Saukonpaadenranta 2Other health care services · NACE 86909Est. 200680 employees
Revenue 2025
EUR 4,2M
-84% vs 2024
EBITDA margin
8.9%
-86% vs 2024
Equity ratio
51.1%
Financial strength
Net profit 2025
EUR 792
+100% vs 2024
| Revenue | EUR 4,2M | -84% |
| EBITDA | EUR 376K | -86% |
| Net profit | EUR 792 | +100% |
| Total assets | EUR 11,9M | -1% |
| Equity | EUR 6,1M | +0% |
| Employees | 80 | — |
Legal name
Docrates Oy
Y-tunnus number
2050681-8
Legal form
Osakeyhtiö
NACE code
86909 · Other health care services
Founded
31. heinäkuuta 2006
Share capital
EUR 69 300
Employees
80 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on tuottaa ja myydä terveyden- ja sairaanhoitopalveluja sekä tuottaa tutkimuspalveluja ja siihen liittyvää kirjallisuutta. Lisäksi yhtiön toimialaan kuuluu koulutus- ja neuvontapalvelujen tuottaminen, sairaanhoitokuljetukset ja kotisairaanhoidonpalvelut. Yhtiö voi myös harjoittaa henkilöstön vuokrauspalveluja. Yhtiö voi omistaa, hallita, vuokrata ja myydä huoneistoja sekä kiinteää ja irtainta omaisuutta. Yhtiö voi omistaa ja myydä arvopapereita sekä harjoittaa sijoitustoimintaa.
Address
Saukonpaadenranta 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 22 888 | 25 977 | 27 754 | 26 091 | 4 242 |
| Staff expenses | −6 454 | −6 793 | −7 816 | −8 000 | −1 214 |
| EBITDA | 4 103 | 5 059 | 4 643 | 2 726 | 376 |
| Depreciation & amort. | −1 563 | −1 675 | −1 849 | −3 373 | −340 |
| EBIT | 2 540 | 3 384 | 2 794 | −647 | 36 |
| Net financials | −52 | −43 | −81 | −22 | −34 |
| Profit before tax | 2 488 | 3 341 | 2 713 | −669 | 2 |
| Tax | −0 | 568 | 486 | −0 | 1 |
| Net profit | 2 488 | 2 773 | 2 226 | −273 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 779 | 13 790 | 13 437 | 12 095 | 11 920 |
| Equity | 7 368 | 8 141 | 8 367 | 6 094 | 6 095 |
| Long-term debt | 2 156 | 1 181 | 648 | 2 516 | 2 516 |
| Short-term debt | 4 255 | 4 467 | 4 421 | 3 387 | 3 225 |
| Total debt | 6 411 | 5 649 | 5 070 | 5 903 | 5 742 |
EBITDA margin
8.9%
This company
15.8%
Market median
-44% vs market
20212025
Equity ratio
51.1%
This company
38.2%
Market median
+34% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-02-28
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (5) | ||
HH Person with significant control | Person with significant control | 2010 – 2024 |
MK Person with significant control | Person with significant control | 2023 – 2024 |
IJ Chief Executive Officer | Chief Executive Officer | 2017 – 2025 |
TA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2017 – 2021 |
KA | Audit | 2008 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairperson | 2024 | |
| Board of Directors | 2024 | |
| Former (8) | ||
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2018 – 2024 | |
| Chairperson | 2018 – 2024 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Docrates Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harri Henrikki Puurunen | Person with significant control | 0 companies |
| Marja Kristiina Saviluoto | Person with significant control | 0 companies |
| Aino Johanna Asklöf | Chief Executive Officer | 0 companies |
| Ilpo Jaakko Tolonen | Chief Executive Officer | 0 companies |
| Tom Anders Wiklund | Deputy Chief Executive Officer | 0 companies |
| Kirsi Annele Jantunen | Audit | 0 companies |
| Anssi Petteri Hartiala | Board of Directors | 0 companies |
| Herkko Samppa Soininen | Chairperson | 0 companies |
| Laura Elina Tarkka | Board of Directors | 0 companies |
| Antti Jussi Aho | Board of Directors | 0 companies |
| Kirsi Terhikki Komi | Chairperson | 0 companies |
| Katri Kristiina Harra | Board of Directors | 0 companies |
| Sami Jukka Petteri Koski | Board of Directors | 0 companies |
| Annakaija Lappalainen | Board of Directors | 0 companies |
| Miia Eila Kristiina Porkkala | Board of Directors | 0 companies |
| Juha Antti Tuominen | Board of Directors | 0 companies |
| Laura Kaarina Ämmälä | Board of Directors | 0 companies |